ATLAS / Macro Radar / Reporting / RLYB

Rallybio Corp (RLYB) reporting calendar

Rallybio Corp files periodic reports with the SEC as RLYB on Nasdaq. Atlas tracks 20 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
19 Jul 2026 – 26 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
13 May 2026
Reports on record
20

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open RLYB market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202613 May 202643 days0001628280-26-034580
10-K31 Dec 202516 Mar 202675 days0001628280-26-018261
10-Q30 Sep 20256 Nov 202537 days0001739410-25-000132
10-Q30 Jun 20257 Aug 202538 days0001739410-25-000112
10-Q31 Mar 20258 May 202538 days0001739410-25-000061
10-K31 Dec 202413 Mar 202572 days0001739410-25-000040
10-Q30 Sep 20247 Nov 202438 days0001739410-24-000136
10-Q30 Jun 20248 Aug 202439 days0001739410-24-000115
10-Q31 Mar 20249 May 202439 days0001739410-24-000057
10-K31 Dec 202312 Mar 202472 days0001739410-24-000035
10-Q30 Sep 20239 Nov 202340 days0001739410-23-000014
10-Q30 Jun 20238 Aug 202339 days0001739410-23-000007
10-Q31 Mar 20239 May 202339 days0000950170-23-019165
10-K31 Dec 20226 Mar 202365 days0000950170-23-006264
10-Q30 Sep 20227 Nov 202238 days0000950170-22-022342
10-Q30 Jun 20228 Aug 202239 days0000950170-22-015571
10-Q31 Mar 202210 May 202240 days0000950170-22-009013
10-K31 Dec 202115 Mar 202274 days0000950170-22-003767
10-Q30 Sep 202110 Nov 202141 days0000950170-21-004125
10-Q30 Jun 20219 Sep 202171 days0000950170-21-001740

Source: SEC EDGAR company submissions for CIK 0001739410. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.